NPPA and cardiac hypertrophy: In diabetic mouse models, the combination of CPPPNBs@FGF21 with low-frequency ultrasound was observed to significantly downregulate the expression of atrial natriuretic peptide (ANP) and caspase-3, while effectively preventing myocardial hypertrophy, apoptosis, and interstitial fibrosis (86).